TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects.
Busserolles J, Ben Soussia I, Pouchol L, Marie N, Meleine M, Devilliers M, Judon C, Schopp J, Clémenceau L, Poupon L, Chapuy E, Richard S, Noble F, Lesage F, Ducki S, Eschalier A, Lolignier S.
Busserolles J, et al. Among authors: poupon l.
Br J Pharmacol. 2020 Oct;177(20):4782-4795. doi: 10.1111/bph.15243. Epub 2020 Sep 21.
Br J Pharmacol. 2020.
PMID: 32851651
Free PMC article.